Harbour Biomed Funding: $263M Raised, Series C (2020)
Harbour Biomed is based in Suzhou, China. It has raised $263M in total funding. Latest round: Series C.
Harbour Biomed funding overview
Harbour Biomed is based in Suzhou, China. Harbour Biomed has raised $263M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in July 2020. The round record for Harbour Biomed runs through 2020; nothing later has been disclosed. Investors on record include OrbiMed, AEF Greater BAY Area Fund, Country Garden Venture Capital, Gtja Investment Group, Octagon Capital, Sage Partners. 6 distinct backers are named across the disclosed rounds.
Harbour Biomed at a glance
Total raised
$263M
Latest round
Series C
Latest round date
July 2020
Headquarters
Suzhou, China
Notable investors
OrbiMed, AEF Greater BAY Area Fund, Country Garden Venture Capital, Gtja Investment Group, Octagon Capital, Sage Partners
Frequently asked about Harbour Biomed funding
How much has Harbour Biomed raised?
Harbour Biomed has raised $263M in total disclosed funding across the rounds on record.
Who has invested in Harbour Biomed?
OrbiMed, AEF Greater BAY Area Fund, Country Garden Venture Capital, Gtja Investment Group, Octagon Capital, Sage Partners are named among the investors backing Harbour Biomed.
What was the latest Harbour Biomed funding round?
The most recent disclosed round is a Series C, announced in July 2020.
Where is Harbour Biomed based?
Harbour Biomed is based in Suzhou, China.
When did Harbour Biomed last raise?
The last disclosed Harbour Biomed round closed in July 2020 at Series C.
Harbour Biomed totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Suzhou below to benchmark round size and investor mix.
